Health Catalyst, Inc.
Health Catalyst, Inc. (NASDAQ: HCAT) is trading at $1.74, about ₹167 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET. Indian residents can buy Health Catalyst from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$1.73
Today's high
$1.77
52 week low
$0.96
52 week high
$3.62
HCAT opened at $1.74, closed previously at $1.74, and has traded between $0.96 and $3.62 over the past 52 weeks.
About
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
Key statistics
Avg. volume
1.31M
Market cap
$128.58M
P/E Ratio
-0.47
Price-to-sales ratio
0.44
Enterprise value
$237.96M
Free cash flow yield
10.16%
Debt-to-equity ratio
1.69
Return on equity
-129.70%
ROIC
-21.13%
Beta
1.53
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$311.14M
Earnings per share
-$2.55
Free cash flow
-$237.00K
Net profit margin
-90.61%
Gross margin
46.44%
EBITDA
-$110.35M
Revenue growth
1.48%
Similar securities
This is not an investment recommendation
How to buy Health Catalyst from India
Indian residents can buy Health Catalyst shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Health Catalyst and place an order
Find Health Catalyst by name or by its ticker, HCAT, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Health Catalyst trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Health Catalyst position in USD and INR. Health Catalyst pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Health Catalyst from India
Trading and taxes when buying Health Catalyst from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneHealth Catalyst does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Health Catalyst stock?
Yes. Health Catalyst (HCAT) has been listed on NASDAQ since 2019, in the Medical - Healthcare Information Services industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Health Catalyst share cost in rupees?
One Health Catalyst share is $1.74 — about ₹167 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the Health Catalyst price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Health Catalyst from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Health Catalyst?
Yes. One Health Catalyst share is $1.74, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Health Catalyst.
How are gains on Health Catalyst shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Health Catalyst price. Paasa issues a capital-gains statement for your return.
Does Health Catalyst pay a dividend?
No. Health Catalyst does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Health Catalyst from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Health Catalyst shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Health Catalyst shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Health Catalyst holding, its cost and its closing value.
How do I sell Health Catalyst and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.